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Abstract
BACKGROUND—Few population studies have described the heritability and intrafamilial
concordance of the retinal microvessels, or the genetic or environmental correlations of the
phenotypes of these vessels.
METHODS—We randomly selected 413 participants from 70 families (mean age, 51.5 years;
50.1% women) from a Flemish population. We post-processed retinal images using IVAN
software to generate the central retinal arteriole equivalent (CRAE), central retinal venule
equivalent (CRVE), and arteriole-to-venule-ratio (AVR) from these images. We used SAGE
version 6.2 and SAS version 9.2 to compute multivariate-adjusted estimates of heritability and
intrafamilial correlations of the CRAE, CRVE, and AVR of the retinal microvessels in the images.
RESULTS—Sex, age, mean arterial pressure, and smoking explained up to 12.7% of the variance
of the phenotypes of the retinal microvessels of the study participants. With adjustments applied
for these covariates, the heritability estimates of CRAE, CRVE, and AVR were 0.213 (P = 0.044),
0.339 (P = 0.010), and 0.272 (P = 0.004), respectively. The parent–offspring correlations for
CRAE, CRVE, and AVR were 0.118 (NS), 0.225 (P < 0.01), and 0.215 (P < 0.05), respectively.
The corresponding values were 0.222 (P < 0.05), 0.213 (P < 0.05), and 0.390 (P < 0.001) for sib–
sib correlations, respectively. The genetic and environmental correlations between CRAE and
CRVE were 0.360 and 0.545 (P < 0.001 for both).
CONCLUSION—Our study showed moderate heritability for CRAE, CRVE, and AVR, and a
significant genetic correlation of CRAE with CRVE in the Flemish population of our study. These
findings suggest that genetic factors influence the diameter of the retinal microvessels, and that
CRAE and CRVE share some genetic determinants.
© American Journal of Hypertension, Ltd 2013. All rights reserved.
Correspondence: Jan A. Staessen (jan.staessen@med.kuleuven.be)..
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Nonmydriatic imaging systems allow easy and noninvasive visualization of the retinal
microvessels, and thereby provide a “window” to assess the microcirculation in the central
nervous system (CNS).1 Reduced arteriolar diameter predicts the risk of hypertension,2
stroke,3 and cardiovascular death.4 Genome-wide linkage studies,5-8 although not consistent
in identifying specifically responsible loci, have suggested that genetic factors contribute
substantially to interindividual variation in the diameter of the retinal microvessels.
Heritability refers to the concordance in phenotypic traits between related individuals. Twin
studies6,9,10 have found a range of from 56%–70% and of 62%–83% in the heritability of
the central retinal arteriole equivalent (CRAE) and central retinal venule equivalent
(CRVE), respectively. To the best of our knowledge, only one previous study assessed the
familial aggregation of the CRAE and CRVE in a population–based cohort, of which 99% of
the members were white Americans.11 In the present study, we assessed the heritability,
intrafamilial concordance, and genetic and environmental correlations of the diameters of
the central retinal vessels in complex pedigrees randomly recruited from a Flemish
population.
METHODS
Study population
Previous reports provide a detailed description of the recruitment of the participants in the
Flemish Study on Environment, Genes and Health Outcomes (FLEMENGHO).12 From
August 1985 until November 1990, a random sample was taken of the households in a
geographically defined area of Northern Belgium with the goal of enrolling, in each of six
subgroups, an equal number of participants on the basis of sex and age (20–39, 40–59, and ≥
60 years). All household members with a minimum age of 20 years were invited to
participate in the study, provided that the quotas for their groups in terms of sex and age had
not yet been fulfilled. From June 1996 to January 2004, recruitment of families continued,
with the participants in the 1985–1990 sample as index persons, with the added inclusion of
subjects under 20 years of age. The participation rate at enrolment was 65.0%.12 From
November 2007 to January 2012, we reinvited former participants to a follow-up
examination at our field center, which included imaging of their retinal microvessels. We
obtained written informed consent from 662 of the participants in the earlier study (a rate of
75.3%). We excluded 132 singletons (unrelated participants), and 117 participants in the
earlier study because of poor-quality retinal images (n = 113), missing information on
covariates (n = 1), or outlying data points exceeding 3 SD from the mean (n = 3). Our final
analyses represented 413 participants.
Clinical and biochemical measurements
For at least 3 hours before the retinal examination for the study, the participants refrained
from heavy exercise, smoking, and intake of alcohol and caffeine-containing beverages.
Trained nurses measured the subjects’ anthropometric characteristics and blood pressure
(BP). Body mass index (BMI) was calculated as the subject’s weight in kilograms divided
by the square of the subject’s height in meters. The nurses also administered a questionnaire
designed to collect information about each participant’s recent medical history, smoking and
drinking habits, and intake of medications.
Liu et al. Page 2
Am J Hypertens. Author manuscript; available in PMC 2013 March 25.
 Europe PM
C Funders A
uthor M
anuscripts
 Europe PM
C Funders A
uthor M
anuscripts
Each subject’s BP was recorded as the average of five consecutive readings taken after the
subjects had rested in the sitting position for at least 5 minutes. Hypertension was defined as
a BP of at least 140 mm Hg systolic or 90 mm Hg diastolic or the use of antihypertensive
medication or both. Mean arterial pressure (MAP) was calculated as the diastolic BP (DBP)
plus one third of the difference between the systolic BP and DBP. On the day of the retinal
examination, with the subjects fasting for at least 8 hours, venous blood samples were
drawn. Using standardized automated methods, we measured plasma glucose and serum
total and high-density lipoprotein (HDL) cholesterol. We computed the Homeostasis Model
Assessment-insulin resistance index (HOMA-IR) as the fasting serum insulin concentration
multiplied by the fasting plasma glucose concentration with the product divided by 22.5.
Diabetes mellitus was defined as a fasting plasma glucose concentration of 6.99 mmol/l (126
mg/dl) or more or the use of antidiabetic medication.
Microvascular phenotyping
We phenotyped the subject’s retinal arterioles and venules as previously described.13 To
dilate the pupil, retinal imaging was done in a dimly lit examination room after the subjects
had accommodated to darkness for at least 5 minutes. Trained observers made photographs
of each eye of each subject with a Canon Cr-DGi nonmydriatic retinal visualization system
combined with a Canon D-50 digital camera (Canon, Kyoto, Japan). After converting JPEG
to TIFF images, using the Phatch (http://photobatch.stani.be/) photographic and digital
graphics processing system, two trained observers identified individual retinal arterioles and
venules in each image, using the validated, computer-assisted IVAN program (Vasculo-
matic ala Nicola, version 1.1, Department of Ophthalmology and Visual Science, University
of Wisconsin–Madison, Madison, WI).14 This software system combines individual
measurements of retinal blood vessels into the CRAE and the CRVE, which are summary
indexes based on formulas developed by Parr and Spears,15 Hubbard,16 and Knudtson.17
The arteriole-to-venule ratio (AVR) is calculated as the CRAE divided by the CRVE. The
intraclass correlation coefficients of CRAE, CRVE, and AVR were 0.81, 0.63 and 0.70 for
observer 1, respectively, and 0.69, 0.71, and 0.70 for observer 2. The reproducibilities of
CRAE, CRVE, and AVR were 13.2%, 8.4%, and 9.0%, respectively, for observer 1, and
10.3%, 10.8%, and 16.2, respectively, for observer 2.17 The interobserver reproducibilities
of CRAE, CRVE, and AVR were 10.8%, 9.9% and 14.6%, respectively.18
Statistical analysis
For management of the study database and statistical analysis, we used SAS software
version 9.2 (SAS Institute, Cary, NC). We applied a logarithmic transformation to normalize
the distributions of insulin and insulin resistance determined with the HOMA index. The
central tendency and spread of the distributions were presented as the arithmetic mean
(±SD) or geometric mean (interquartile range). We compared means and proportions
through the use of Student’s t-test and the chi-squared test, respectively. Our statistical
methods also included single and multiple linear regressions. We searched for possible
covariates of the arterial phenotypes through a stepwise regression procedure with the P-
values for independent variables to enter and to stay in the model set at 0.15. As covariates
we considered sex, age, BMI, MAP, the ratio of HDL to total cholesterol, the HOMA-IR,
and design variables (0, 1), coding for current smoking, alcohol intake, and the use of
various classes of antihypertensive drugs (diuretics, beta-blockers, vasodilators, and
inhibitors of the renin–angiotensin–aldosterone system). To estimate heritability and to
calculate the intrafamilial and genetic and environmental correlations of the retinal vascular
measures examined in the study, we used the 2012 Statistical Analysis for Genetic
Epidemiology (S.A.G.E.) software package, release 6.2 (http://darwin.cwru.edu/) (S.A.G.E.,
Case Western Reserve University, Cleveland, OH). We applied the ASSOC and the FCOR
procedures of S.A.G.E. software to respectively assess heritability and intrafamilial
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correlations in the narrow sense. We estimated heritability by assuming multivariate
normality after a simultaneously estimated power transformation. The ASSOC procedure of
the S.A.G.E. software uses a multiple linear regression model in which the residual variance
is partitioned into the sum of an additive polygenic component, a sibling component, and an
individual-specific random component. The FCOR procedure estimates familial correlations
and their asymptotic standard errors via the Pearson product-moment method. Heritability
(h2) was estimated as the polygenic component divided by the total residual variance.
We calculated the genetic and environmental correlations between CRAE and CRVE with
adjustments applied for covariates. With the assumption of a lack of dominance variance
and no interaction between the genetic and environmental variance components, the
variance of a trait is given by: V = G + E, where G is the additive polygenic component and
E is the environmental component. The total phenotypic correlation between two traits (ρP)
can be partitioned into a genetic (ρG) and an environmental (ρE) component given by the
equation:
where h12 and h22 represent the heritability of the two traits, and ρG and ρE are the genetic
and environmental correlations, respectively. The significance of ρG and ρE suggests the
influence of shared genes and shared environmental factors on two traits.19 We compared
ρG and ρE using Fisher’s Z transformation.
RESULTS
Characteristics of study participants
Our study sample included 413 subjects from 70 complex pedigrees with sizes ranging from
2 to 37 individuals and encompassing from 1 to 3 generations. Table 1 lists the
characteristics of the study participants by generation. Compared with the first generation,
the second generation more frequently reported drinking but less frequently used
antihypertensive drugs. As compared with the second generation, the third generation had
lower values of BMI, BP, and total cholesterol, but had a higher HDL-to-total cholesterol
ratio, less frequently reported drinking alcohol. and had a lower prevalence of hypertension.
Determinants of retinal microvascular phenotypes
In our stepwise regression analysis (Table 2), the covariates considered for entry into the
model were sex, age, BMI, MAP, HDL-to-total cholesterol ratio, HOMA-IR value,
smoking, drinking of alcohol, and antihypertensive drug treatment. Sex and age were forced
into the model. The CRAE was larger in women than in men and in smokers than in
nonsmokers, and was inversely and independently associated with age and MAP. The same
tendencies were observed for CRVE. The AVR was higher in women than in men and
tended to decrease with age. The amount of variance explained ranged from 2.1% to 12.7%.
Heritability, genetic, and environmental correlation
We estimated the h2 of retinal-vessel diameters, using incremental adjustments. Our model 1
included sex and age as covariates; model 2 was additionally adjusted for MAP; model 3
also included current smoking; and model 4 additionally accounted for antihypertensive
drug treatment. The heritability estimates for CRAE, CRVE, and AVR were significant (h2
≥ 0.213; P ≤ 0.044) with the exception of that for CRAE in model 1 (h2 ≥ 0.201; P = 0.064).
The heritability estimates ranged from 0.201 to 0.252 for CRAE, from 0.281 to 0.339 for
CRVE, and from 0.272 to 0.310 for AVR. The heritability estimates for body height and
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weight, computed as a reference, were 0.389 and 0.492, respectively, and 0.754 and 0.531
when adjusted for sex and age (Table 3). The total adjusted phenotypic correlation (ρP) of
CRAE with CRVE was significant (ρP = 0.490; P < 0.001; Figure 1), and we therefore
partitioned it into a genetic (ρG) and an environmental (ρE) component. The genetic
correlation was significant (ρG = 0.360, P < 0.001), although weaker (P = 0.0008) than the
environmental correlation (ρE = 0.545, P < 0.001).
Familial correlation
With adjustment applied as in Table 3, the sib–sib correlations (n = 176) ranged from 0.213
to 0.390 (P ≤ 0.015) for the retinal phenotypes, and were 0.441 (P = 0.0001) and 0.391 (P =
0.0003) for body height and weight, respectively (Table 4). The adjusted parent–offspring
correlations (n = 174) were significant for CRVE (r = 0.225; P = 0.009), AVR (r = 0.215; P
= 0.0154), body height (r = 0.397; P < 0.0001), and weight (r = 0.325; P = 0.013).
DISCUSSION
In the family-based population study described here, we observed a moderate but significant
heritability of retinal microvascular phenotypes. The sib–sib correlations were significant for
all of the phenotypes that we assessed, but the parent–offspring correlations were significant
only for CRVE and AVR, and not for CRAE. One possible interpretation of these findings is
that all retinal microvascular phenotypes are genetically determined, and that the influence
of environmental factors is stronger for CRAE than for CRVE. Our study adds to the
existing literature because: (i) in contrast to twin studies,6,9,10 our participants represented
an unbiasedm randomly recruited population sample; (ii) we estimated both heritability and
intrafamilial correlations in the same study participants,6,9-11 (iii) in contrast to previous
studies,6,10,11 we partitioned the total phenotypic correlation between CRAE and CRVE into
genetic and environmental components; (iv) our analyses were more comprehensively
adjusted than those in other studies6,9-11; and (v) we used a nonmydriatic method to obtain
our retinal images.6,9-11
In keeping with other studies, 6,9-11 we noticed that CRAE tended to have a lower
heritability than CRVE. In a genomewide association study, Ikram and colleagues observed
associations of CRVE with four loci (19q13, 6q24, 12q24, and 5q14), whereas none of the
associations for CRAE reached genome-wide significance. Ikram et al. speculated that the
genetic influence on CRAE might be attenuated because of the overriding effects of age and
BP on the retinal microvasculature. The Australian Twins Eye Study involved 374
monozygotic and 536 dizygotic twin pairs and 322 siblings.6 With adjustments applied for
sex, age, and BMI, but not BP, the heritability estimates for CRAE and CRVE in the
Tasmanian study were 59.4% and 61.7% and 56.5% and 64.2% in the Brisbane study. A
study in Copenhagen of the association of retinal arterial and venous diameter with the risk
of cardiovascular disease involved 55 monozygotic and 18 dizygotic, same-sex healthy twin
pairs.10 The Danish researchers adjusted for sex, age, smoking, cholesterol, and glucose
tolerance in various combinations, but did not present analyses adjusted for all covariates in
combination.10 Heritability estimates in the Danish study were 70% for CRAE and 83% for
CRVE.10 As exemplified by our current findings and the literature that we reviewed,6,9,10
heritability estimates in twin studies are usually larger than in population surveys because of
the use of different methods of statistical estimation20 or because twins may share a
common environment to a greater extent than do members of complex pedigrees, and if so, a
portion of the environmental factors that twins share may be partitioned into genetic
variance. Heritability estimates usually decrease with more comprehensive adjustment.
In the present study we also computed intrafamilial correlation coefficients. Simple product-
moment correlation coefficients can be used as a measure of the degree of concordance
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(positive correlations) or discordance (negative correlations) of a trait between family
members, as suggested in 1979 by the Framingham investigators.21 However, these
correlation coefficients do not eliminate the problem of using a particular individual’s data
more than once, such as when correlating information between parents and offspring or
between sibs.
We found significant sib–sib correlations for CRAE, CRVE, and AVR. However, the
parent–offspring correlations were significant only for CRVE and AVR. In the Beaver Dam
Eye Study,11 with adjustment for sex, age, MAP, and smoking, the sib–sib correlations for
CRAE, CRVE, and AVR were 0.20, 0.23 and 0.12, respectively. The corresponding parent–
offspring correlations were 0.27, 0.24, and 0.16. Thus, in the Beaver Dam Eye Study,11 the
parent–offspring and sib–sib correlations were similar. However, the avuncular correlations
amounted to about half of the parent–offspring correlations, and the cousin correlations were
half of the avuncular correlations.11 As in the current study, none of the spouse–spouse
correlations in the Beaver Dam Eye Study was significant.11 The investigators in the study
concluded that the pattern of correlations that they observed was consistent with a genetic
component for CRVE and AVR.11 In their study, CRAE also showed some genetic
component, but also seemed to be influenced by environmental factorsm as reflected by the
similar avuncular and cousin correlations found in the study.11
We partitioned the total phenotypic correlation between CRAE and CRVE into a genetic and
an environmental component. The correlations of the genetic and environmental components
were 0.360 and 0.545, respectively. Host factors, such as age, MAP, and lifestyle, including
smoking, might explain why the environmental correlation was greater than the genetic
correlation. Fahy et al.9 estimated the genetic and environmental correlations of CRAE with
CRVE in 706 monozygotic and 757 dizygotic white female twins. They partitioned the
covariance between CRAE and CRVE into additive genetic, common environmental, and
unique environmental factors,9 and assumed that the correlation between latent genetic
factors was 1.0 in monozygotic twins and 0.5 in dizygotic twins. They found that 77% of the
covariance between CRAE and CRVE was due to additive genetic factors, with the
remaining 23% attributable to unique environmental effects.9 Fahy et al. replicated these
findings in 1981 in twins from the Australian Twins Eye Study.9 When comparing our
results in the present study with those reported by Fahy et al., one should keep in mind that
heritability estimates are usually higher in twins than in complex pedigrees recruited from
populations,20 and that the methods used to compute the genetic and environmental
contributions in our study and the study by Fahy et al. were different.
Our study should be interpreted within the context of its potential limitations. First, our
sample size was relatively small, especially in terms of the number of families that consisted
of two or more generations. This might have explained the relatively low heritability of the
retinal-vessel diameters found in our study. However, the heritability and intrafamilial
correlations of body height and weight in our study were comparable with those reported in
previous population20,22,23 and twin24 studies, suggesting that our study was adequately
statistically powered. Moreover, EkstrØm et al. found that 200–400 individuals are
generally sufficient to provide reasonably robust estimates of heritability as defined in our
present study.25
Second, we did not prove the natural descent of the offspring in our study. However, in a
prior study based on the same population as in the present study,20 only two parent–
offspring relations had to removed, on the basis of Mendelian inconsistency in the ABO and
Rhesus blood-type groups. These two parent–offspring pairs were not included in the current
study. Third, we did not exclude participants being treated with antihypertensive drugs.
However, adjustment for treatment and other covariates did not affect our results. Lastly, we
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did not adjust for refractive errors. However, previous studies showed that correction for
refraction did not materially alter estimates of heritability and intrafamilial correlations.11
Furthermore, refractive error might influence CRAE and CRVE, but not AVR,26 which in
the present study showed significant heritability.
In conclusion, our findings in the study described here suggest that genetic factors influence
the diameter of the retinal microvessels. Estimates of heritability of retinal microvascular
phenotypes were little affected when BP was taken into account, suggesting that the genes
involved might not necessarily act through BP, in accord with the finding in several studies
that retinal arteriolar narrowing may precede the development of hypertension,27-30
cardiovascular disease,31 and stroke.3 The significant genetic correlation between arteriolar
and venular diameters suggests that these traits share some common genetic determinants.
Genetic factors may also directly influence the structure and function of the retinal
microvasculature.
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Figure 1.
Genetic and environmental correlations between central retinal arteriolar equivalent (CRAE)
and central retinal venular equivalent (CRVE). Correlation coefficients were adjusted as in
model 4 (Table 3). Abbreviations: ρP, total phenotypic correlation; ρG, genetic correlation;
ρE, environmental correlation. Values on ordinate are correlation coefficients (95%
confidence interval).
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Table 1
Characteristics of study participants
Characteristic Generation 1 Generation 2 Generation 3
Number 142 85 186
Arithmetic mean (± SD)
 Age, years) 62.1 ± 9.3 54.2 ± 8.8‡ 42.2 ± 14.9‡
 Body mass index, kg/m2 27.7 ± 4.5 27.2 ± 3.9 25.5 ± 4.2†
 Systolic blood pressure, mm Hg 131.5 ± 17.1 127.8 ± 16.2 122.3 ± 13.8†
 Diastolic blood pressure, mm Hg 81.5 ± 9.0 81.8 ± 10.7 77.2 ± 11.1†
 Mean arterial pressure, mm Hg 98.2 ± 10.2 97.2 ± 11.7 92.2 ± 11.0‡
 Total cholesterol, mmol/l 5.42 ± 0.87 5.39 ± 0.91 4.96 ± 0.88‡
 HDL cholesterol, mmol/l 1.43 ± 0.36 1.43 ± 0.35 1.42 ± 0.32
 Ratio of HDL-to-total cholesterol 0.267 ± 0.066 0.270 ± 0.076 0.293 ± 0.074*
 Plasma glucose, mmol/l 5.06 ± 0.62 5.06 ± 0.91 4.92 ± 0.90
 Central retinal arteriole equivalent, μm 151.4 ± 15.9 152.9 ± 13.0 153.8 ± 14.7
 Central retinal venule equivalent, μm 215.3 ± 20.4 220.1 ± 20.6 219.0 ± 19.8
 Arteriole-to-venule ratio 0.706 ± 0.069 0.698 ± 0.060 0.705 ± 0.060
Geometric mean, 95% IQR
 Insulin, mU/l 5 (3 to 9) 6 (4 to 10) 5 (3 to 9)
 HOMA insulin resistance 1.21 (0.69 to 1.89) 1.18 (0.77 to 2.29) 1.11 (0.64 to 2.06)
Subjects with characteristic, n (%)
 Current smoking 37 (26.1) 20 (23.5) 41 (22.0)
 Drinking alcohol 41 (28.9) 38 (44.7)* 60 (32.3)*
 Hypertension 52 (36.6) 23 (27.1) 27 (14.5)*
 Diabetes 1 (0.70) 0 1 (0.54)
Antihypertensive drug treatment 37 (26.1) 7 (8.2)‡ 13 (7.0)
 Diuretics 16 (11.3) 5 (5.9) 3 (1.6)
 Beta-blockers 27 (19.0) 4 (4.7)† 11 (5.9)
 Vasodilators 6 (4.2) 3 (3.5) 0*
 RAAS inhibitors 8 (5.6) 0* 1 (0.54)
Hypertension was defined as a blood pressure ≥ 140 mm Hg systolic or ≥ 90 mm Hg diastolic, or the use of antihypertensive drugs. Diabetes was
defined as a fasting plasma glucose concentration ≥ 6.99 mmol/l or the use of antidiabetic drugs. Vasodilators included calcium antagonists and
alpha-blockers. Renin–angiotensin–aldosterone system inhibitors included converting enzyme inhibitors and angiotensin II receptor blockers.
Abbreviations: HDL, high-density lipoprotein; HOMA, Homeostasis Assessment Model; IQR, interquartile range; RAAS, renin-angiotensin-
aldosterone system.
*P < 0.05
†P < 0.01
‡P < 0.001, significance of difference between generations.
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Table 2
Determinants of retinal vascular phenotypes
Determinant CRAE CRVE AVR
R2 0.127 0.073 0.021
Regression coefficients
Female 4.19 ± 1.38† 1.82 ± 1.95 0.013 ± 0.006*
Age (+10 years)
−1.58 ± 0.49† −1.30 ± 0.71 −3.55 ± 2.06 (×10−2)
Mean arterial pressure (+10 mm Hg)
−2.63 ± 0.66‡ −1.92 ± 0.93* …
Smoker 3.82 ± 1.61* 8.39 ± 2.27‡ …
Abbrevaitions: AVR, arteriole-to-venule ratio; CRAE, central retinal arteriole equivalent; CRVE, central retinal venule equivalent.
The covariables considered for entry into the model were sex, age, body mass index, mean arterial pressure, ratio of high-density lipid cholesterol
to total cholesterol, Homeostasis Assessment Model-insulin resistance, smoking and drinking, and antihypertensive drug treatment. Sex and age
were forced into the models.
*P < 0.05
†P < 0.01
‡P < 0.001
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